Skip to content

Custom iPSC Services

More Effective Disease Modeling & Screening Stem From Ncardia

When you need custom iPSC services to drive progress in drug discovery, screening, disease modeling, personalized medicine and preclinical cell therapy, partner with Ncardia, the proven iPSC experts.

Ncardia-22

Fully Custom iPSC Services for Every Stage

Explore reprogramming, differentiation and gene editing services tailored to your research goals.

reprogramming-square

iPSC Reprogramming

Select your preferred starting material and let our team streamline sourcing and reprogramming while you focus on research.

Explore iPSC Reprogramming

differentiation-square

iPSC Differentiation

Discover differentiation procedures for functional cells at the scale needed for high-throughput screening campaigns, preclinical cell therapy and tissue/organ engineering purposes.

Explore iPSC Differentiation

gene-editing-square

iPSC Gene Editing

Get the highest knock-out/knock-in precision and efficiency with Ncardia’s proprietary STAR-CRISPR technology.

Explore iPSC Gene Editing

How Ncardia Streamlines the Creation of Patient- or Disease-Specific Cellular Models

By combining tissue or cell sample acquisition, iPSC generation and precise gene editing in a single, coordinated pipeline, our custom iPSC services help researchers reduce variability, save time and improve reproducibility.

Our seamless approach enables high-throughput production of genetically defined iPSC lines. It also minimizes batch effects and simplifies quality control, ensuring consistency from sample intake to final edited lines.

custom_cell_supply
star-crispr

A Streamlined Path to iPSC Gene Editing Stems From STAR-CRISPR

Traditional CRISPR can edit DNA at unintended locations, but our proprietary STAR-CRISPR technology provides unparalleled efficiencies in gene knock-in and knock-out and minimizes off-target editing.

It’s ideal for key applications including:

  • Establish disease modeling platforms
  • Characterization of underlying mechanisms of pathogenic disease-causing mutations
  • Investigate variants of unknown significance (VUS)
  • Perform studies for target validation
  • Perform functional high-throughput screens (HTS) for target identification

Partner With the Proven iPSC Experts

Are you ready to confidently advance your therapeutic candidates?

Start a Conversation